Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04446325
What this trial is testing

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Who this might be right for
Lateral Amyotrophic SclerosisVenous Thrombo-embolic Desease
University Hospital, Brest 227
Testing effectiveness (Phase 2)Study completedNCT04165850
What this trial is testing

Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
NeuroSense Therapeutics Ltd. 16
Not applicableStudy completedNCT00718497
What this trial is testing

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Not applicableUnknownNCT06368076
What this trial is testing

High-intensity Interval Training in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Rigshospitalet, Denmark 20
Testing effectiveness (Phase 2)Study completedNCT00397423
What this trial is testing

G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University 40
Not applicableUnknownNCT06169696
What this trial is testing

EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis

Who this might be right for
Neurologic DisorderParalysisParalysis; Stroke+5 more
Synaptrix Labs Inc. 6
Large-scale testing (Phase 3)Study completedNCT01645787
What this trial is testing

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

Who this might be right for
Spinal Muscular Atrophy
Columbia University 11
Testing effectiveness (Phase 2)Study completedNCT03921528
What this trial is testing

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+6 more
Scholar Rock, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT01884571
What this trial is testing

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Emory University 31
Not applicableWithdrawnNCT03664206
What this trial is testing

Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseCortical Excitability
Sándor Beniczky
Early research (Phase 1)Active Not RecruitingNCT05695521
What this trial is testing

Regulatory T Cells for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Cellenkos, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00661453
What this trial is testing

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

Who this might be right for
Spinal Muscular Atrophy Type I
University of Utah 40
Not applicableNot Yet RecruitingNCT07596277
What this trial is testing

Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication

Who this might be right for
Spinal Muscular Atrophy 1
Guy's and St Thomas' NHS Foundation Trust 15
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Not applicableUnknownNCT01530438
What this trial is testing

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Caen 90
Testing effectiveness (Phase 2)Study completedNCT00409721
What this trial is testing

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Alberta 42
Early research (Phase 1)Not Yet RecruitingNCT06704347
What this trial is testing

Safety Study of XT-150 in Participants With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Xalud Therapeutics, Inc. 8
Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00919555
What this trial is testing

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Phoenix Neurological Associates, LTD 28
Not applicableEnded earlyNCT01547871
What this trial is testing

Infants With Spinal Muscular Atrophy Type I

Who this might be right for
Spinal Muscular Atrophy
National Institute of Neurological Disorders and Stroke (NINDS) 4
Next Page